Vertex Pharmaceuticals Incorporated (0QZU.L) LSE

389.21

-4.86(-1.23%)

Updated at August 19 07:28AM

Currency In USD

Valuation

Market Cap103.7B
Enterprise Value100.88B
P/E Ratio27.51
PEG Ratio0.06
Price/Sales Ratio8.75
Price/Book Ratio5.83
Enterprise/Revenue8.33
Enterprise/EBITDA20.35

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.32
Operating Margin0.34

Management Effectiveness

Return On Assets0.15
Return On Equity0.22

Income Statement

Revenue11.02B
Revenue/Share44.48
Gross Profit9.49B
EBITDA486.3M
Net Income-535.6M
Diluted EPS-2.08

Balance Sheet

Total Cash6.38B
Total Cash/Share30.36
Total Debt1.53B
Total Debt/Equity0.09
Current Ratio2.52
Book Value Per Share66.91

Price History

52-Week Change-19.32
52-Week High446.29
52-Week Low290.87
Moving Average 50 Days424.38
Moving Average 200 Days373.25

Statistics

Average Volume2,907
Shares Outstanding256.39M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A